Performance analysis of Cognition Therapeutics (CGTX)
Annual Return
Over the past 3 years, CGTX has had an average annual return of -19.15%, underperforming the benchmark SPY, which returned +19.62% annual.
Since Oct 8, 2021, CGTX has had an average annual return of -41.27%, underperforming the benchmark SPY, which returned +13.37% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -25.92% | +92.53% | -62.11% | -11.86% | -66.78% | -50.51% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -19.21% | -0% | -30.33% | +65.88% | -6.38% | -2.49% | -13.10% | -25.92% | |||||
| 2025 | +3.10% | -37.10% | -7.30% | +1.21% | -44.01% | +29.95% | +88.89% | +314.60% | -44.46% | +32.64% | -2.78% | -22.45% | +92.53% |
| 2024 | +22.71% | -8.83% | -12.09% | +4.98% | +2.07% | -14.87% | -39.77% | -28.86% | -34.11% | +0.82% | -14.86% | +74.29% | -62.11% |
| 2023 | -6.14% | -18.79% | +23.78% | -10.12% | +15.14% | -10.72% | -9.28% | -6.62% | -7.08% | -22.25% | -0.91% | +66.74% | -11.86% |
| 2022 | -30.37% | -30.24% | -10.44% | +0.74% | -5.39% | -19.49% | -10.41% | +8.45% | -7.29% | -6.32% | +97.20% | -40.20% | -66.78% |
| 2021 | -5.32% | -28.21% | -27.19% | -50.51% |
Drawdown analysis of Cognition Therapeutics (CGTX)
The maximum drawdown for the CGTX was -98.16%, occurring on May 30, 2025. This drawdown has not yet recovered.
The current CGTX drawdown is -92.30%.
Since Oct 8, 2021 CGTX has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -98.16% | Nov 9, 2021 | 891 | May 30, 2025 | Ongoing | Ongoing | Ongoing |
| -6.81% | Oct 8, 2021 | 5 | Oct 15, 2021 | 17 | Nov 9, 2021 | 22 |